Intelgenx Technologs (OP: IGXT )
0.5548 USD UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Jun 18, 2021 Add to My Watchlist
Stories about Intelgenx Technologs
Psyched: MindMed To Begin Mescaline Trials and Deepak Chopra Partnership, Seelos And Cybin Advance Clinical Research
May 24, 2021
MindMed’s News Spree: Mescaline Trials, Chopra Foundation Partnership and LSD Research MindMed (NASDAQ: MNMD) (NEO: MMED) ...
Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public
May 17, 2021
Two of the most prominent companies in the psychedelics space released their financials for the first quarter of 2021. Compass ...
IntelGenx Corp.(TSXV: IGX) (OTCQB: IGXT)has partnered with Canadian medical cannabis producer Heritage Cannabis Holdings ...
Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week
August 24, 2020
Welcome to theCannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics ...
Earnings Scheduled For August 13, 2020
August 13, 2020
Companies Reporting Before The Bell • Tapestry Inc. (NYSE:TPR) is estimated to report quarterly loss at $0.57 per share on ...
Recap: Intelgenx Technologies Q4 Earnings
March 26, 2020
Shares of Intelgenx Technologies (OTC:IGXT) remained unaffected at $0.26 after the company reported Q4 results. Quarterly ...
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger
March 26, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ...
The Week Ahead In Biotech: Bristol-Myers, Rockwell Medical Await FDA Decisions, COVID-19 Updates In Focus
March 22, 2020
Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus ...
Biotech stocks came under selling pressure in February, although the degree of weakness was not as worse as the broader market, thanks ...
Stocks That Hit 52-Week Lows On Monday
December 23, 2019
Before 10 a.m. ET Monday, 92 stocks hit new 52-week lows. Areas of Significance: Orange (OTC: FNCTF) was the largest firm by ...
A Deep Dive Into Aquestive Following The FDA's Approval Of Riluzole
November 26, 2019
Aquestive Therapeutics Inc (NASDAQ: AQST) made a move this week,gaining about 17% Monday after the FDA approved one of its drugs ...
Tilray Shares Take A Breather, Despite Deal Announcement
September 20, 2018
After more than doubling over four sessions, moving from $109.05 last Friday to $214.06, shares of Canadian pot producer Tilray Inc ...
Bad news is building for this once-hot tech sector
September 20, 2018
So you can't stop looking at weed stocks eh? Our call of the attempts to tear your gaze away, with a bearish call on social media stocks.
BRIEF-Intelgenx Announces Proposed Private Placement
March 20, 2018
* INTELGENX TECHNOLOGIES - AGREEMENT PROVIDING FOR ISSUANCE OF UP TO 15.9 MILLION UNITS AT SUBSCRIPTION PRICE OF US$0.63/UNIT FOR PROCEEDS UP TO US$10 MILLION? Source text for Eikon: Further company...
BRIEF-Intelgenx Announces Proposed Acquisition Of Laboval
March 19, 2018
* INTELGENX TECHNOLOGIES - PROVIDES CLARIFICATION IN RESPONSE TO INVESTOR INQUIRIES ABOUT PRELIMINARY PROXY STATEMENT FILED WITH U.S. SEC ON MARCH 7
BRIEF-Intelgenx Says Its Site Obtained Amended Drug Establishment License For Manufacturing Activities?
December 18, 2017
* INTELGENX-AFTER GOOD MANUFACTURING PRACTICES INSPECTION BY HEALTH CANADA,SITE OBTAINED AMENDED DRUG ESTABLISHMENT LICENSE FOR MANUFACTURING ACTIVITIES? Source text for Eikon: Further company...
BRIEF-IntelGenx Receives Health Canada Clearance To Begin Phase 2a Study With Montelukast Versafilm
December 15, 2017
* INTELGENX RECEIVES HEALTH CANADA CLEARANCE TO BEGIN PHASE 2A STUDY WITH MONTELUKAST VERSAFILM(TM) IN MILD TO MODERATE ALZHEIMER'S DISEASE
BRIEF-Intelgenx to regain exclusive worldwide rights to develop and commercialize rizaport(r)
December 05, 2017
BRIEF-Redhill Biopharma and Intelgenx submit new drug application to FDA for Rizaport® for migraines
November 01, 2017
BRIEF-IntelGenx announces decisions in Suboxone(R) patent litigation
September 06, 2017
BRIEF-IntelGenx Technologies enters agency agreement with Desjardins Securities, others
July 05, 2017
* Says on June 28, co entered agency agreement with Desjardins Securities, Laurentian Bank and Echelon Wealth - SEC filing
BRIEF-Intelgenx and Redhill Biopharma announce marketing approval of rizaport for migraines
April 12, 2017
* Intelgenx and Redhill Biopharma announce marketing approval of rizaport(r) for migraines in Luxembourg
* Intelgenx Technologies Corp files for offering of 8 pct convertible unsecured subordinated debentures due June 30, 2020 of up to C$10 million - sec filing Source text - http://bit.ly/2p1eWiq Further...
BRIEF-Tetra Bio-Pharma, Intelgenx sign agreement for development, commercialization of Dronabinol XL tablet
April 03, 2017
* Tetra Bio-pharma and Intelgenx announce the signing of a definitive agreement for the development and commercialization of a Dronabinol XL tablet
BRIEF-Intelgenx Technologies says Eli Lilly granted Versafilm exclusive license for tadalafil film product under erectile dysfunction dosing patent
March 28, 2017
* Intelgenx Technologies- Eli Lilly granted Intelgenx' Versafilm exclusive license for tadalafil film product under erectile dysfunction dosing patent
BRIEF-Tetra Bio-Pharma, Intelgenx sign ageement to develop and commercialize a dronabinol XL tablet
February 09, 2017
* Tetra Bio-Pharma and Intelgenx announce the signing of a term sheet for the development and commercialization of a dronabinol XL tablet
BRIEF-Intelgenx announces definitive agreement with Chemo Group for a generic CNS tablet
January 04, 2017